Physician profile
Robert Wessel
NPI 1437564556
$26,551.27
in general payments reported to CMS, 2019-2025
18 companies · $14K in 2025
The $14K reported for 2025 was more than what 82% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,027 · 2020: $268 · 2021: $517 · 2022: $906 · 2023: $4,169 · 2024: $5,142 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $5,913 · Travel and Lodging: $5,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,250.00 |
| Food and Beverage | $5,913.13 |
| Travel and Lodging | $5,670.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,639.19 | 2021-2025 | Extremities & Trauma Implants Long Bone Trauma Femoral Fracture |
| Stryker Corporation | $4,742.55 | 2019-2025 | Pro, T2 Alpha, Gamma |
| Novus Surgical Consultants | $2,438.75 | 2023-2025 | |
| Medical Device Business Services, INC. | $1,388.18 | 2019-2024 | Reclaim |
| Si-Bone, INC. | $554.01 | 2022-2025 | |
| Depuy Synthes Sales INC. | $434.34 | 2020-2025 | Na, Va-Lcp, Motoband |
| Kerecis Limited | $368.67 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sanara Medtech INC. | $246.78 | 2021-2024 | Celleraterx |
| Skeletal Dynamics INC | $197.17 | 2024-2025 | Ijs, Implate, Align |
| Zimmer Biomet Holdings, INC. | $109.35 | 2022 | |
| Amgen INC. | $93.59 | 2023 | |
| Biocomposites INC | $87.36 | 2024-2025 | Stimulan |
| Djo, LLC | $75.40 | 2023 | Cmf |
| Acumed LLC | $73.66 | 2023 | Acumed, Innate Implant |
| Ferring Pharmaceuticals INC. | $52.68 | 2024-2025 | Euflexxa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21.89 | 2023 | |
| Endo Pharmaceuticals INC. | $15.23 | 2019 | |
| Integra Lifesciences Corporation | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wessel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.